Testing effectiveness (Phase 2)Study completedNCT04051944
What this trial is testing
Assess Long-term Safety, Tolerability and Efficacy of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Who this might be right for
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
UCB Biopharma SRL 21